$CPQQ .14 DOWN 68% HUGE BUYS COMING IN! $OODH .042

New Post Public Reply Private Reply Replies (0) Message Board
AAAAMHIM
$CPQQ .14 DOWN 68% HUGE BUYS COMING IN!
$OODH .042 STARTING.

CPQQ must be the most undervalued stock on the exchange 

Quick numbers from the Q2 balance sheet.... 

Between Dec 31, 12 and June 30, 13: 

• CPQQ raised their asset value by $3.4 mil or $0.173/share (using shares outstanding @ 19.6 mil) They have total assets of $48,714,190. 
• Thanks to Q2 $3.9 mil reduction in accounts receivable; CPQQ increased cash and cash equivalents by $7.1 mil to $29,236,104. 
• Total liabilities sit at $3.787 mil (a $71,851 increase) 
• Current Book value of this stock $44.917 million. 

Putting these quick facts into perspective, using 19.6 mil shares outstanding: 

• With $29.236 mil in ca$h this stock should be priced at $1.49 just to meet cash equivalent. 

• Or priced at $2.29 to par with the $44.917 mil book value. …a 377% increase. 

If one chooses to price in future earnings using the present 0.29/share & that fact that this management is so blinking good with $$$$; one might see this stock going back around its’ Q1 2010 prices. 



Other notables I enjoyed: 

First and foremost, this reliable management filed its’ Q2 precisely on time…..again. 

CPQQ admits they are off to a slow year, mostly due to the Q1. Holidays and well deserved employee time off. Smart …A company is nothing without good employee morale. Now that they are back to work the quarterly revenue increase is significant. 

I liked reading the statements of operation more than the asset column. The number I truly enjoyed seeing was this one +5.5% ($20,000) that is the increase in selling and admin expenses on page 1. The reason why I like to see a number like this is because it shows this management knows where to throw money and energy when sales are down. It worked too, increasing their accounts receivable department is probably the reason for the $3.9 mil reduction in receivables. 

I also enjoyed reading statements like this: “The decrease in the first half of 2013 was mainly due to lower average selling prices of amorphous alloy cores” A company will sink and drown, if it is not willing to competitively price their product. 

On page one of the Q2 the CEO, Mr. Song, makes some pretty positive and optimistic statements about the remainder of 2013. I take them to heart considering my impression of what an ultraconservative person he may be. With government contracts looking bountiful, I believe Q4 2013 might show another year to year increase in profits. 

It looks as if over 1 million shares of this company is now “institutionally owned” by Concorde Equity. I can only assume they did their homework before buying in, which is always encouraging. 

Q3 2012 CPQQ management was urged by Barron partners CEO to buy back shares and pay a dividend to the shares holders. I don’t know if this would be something I would hold my breath waiting for, as this management seems to like amassing cash, but if they did announce a dividend……… 


GLTA 



Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 256

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 400

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 226

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 363

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

ARK Venture Fund Invests in Umoja's Innovative Cancer Research

Updated Category News Views 268

ARK Venture Fund Invests in Umoja's Innovative Cancer Research Cathie Wood's ARK Venture Fund has made a notable investment in Umoja's Series C funding round, marking a significant milestone for the biotech company. Umoja is dedicated to pioneering a transformative approach to cancer treatment, focusing on enhancing the patient's immune response through novel techniques....

Continue Reading
Hooker Furnishings Shows Solid Sequential Growth in Q2 Results

Updated Category News Views 41

Hooker Furnishings' Second Quarter Performance Hooker Furnishings Corporation (NASDAQ: HOFT), a well-established name in the home furnishings industry for more than a century, recently revealed its financial results for the second quarter of fiscal 2025. The company demonstrated resilience in the face of challenging market conditions. Sales Performance Insights Typically...

Continue Reading
Pulmonx Achieves Remarkable Financial Growth in 2024

Updated Category News Views 352

Pulmonx Achieves Record Financial Success in 2024 Pulmonx Corporation (Nasdaq: LUNG) has made significant strides in its financial performance, demonstrating a remarkable growth trajectory throughout 2024. This globally recognized leader in minimally invasive lung disease treatments reported promising results that highlight its strong business model and commitment to...

Continue Reading
Blue Hat Secures $4.3 Million Through Direct Share Offering

Updated Category News Views 129

Blue Hat Interactive Entertainment Technology Engages in Direct Share Offering Recently, Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) made headlines by announcing its entry into securities purchase agreements allowing it to raise an impressive $4.3 million. This initiative is aimed at bolstering the company's financial stability and enhancing its market...

Continue Reading
Celebrating Innovation: PTx Trimble's OutRun Secures Award

Updated Category News Views 469

PTx Trimble Triumphs with OutRun at the Davidson Prize OutRun Autonomous Grain Cart Now Available in the U.S. PTx Trimble, a collaboration between AGCO and Trimble that started in 2024, has made headlines by launching OutRun, a revolutionary autonomous grain cart that has just clinched the prestigious Davidson Prize at Commodity Classic 2025. This accolade recognizes...

Continue Reading